Abstract. We have previously demonstrated an important role of influx of Cl − rather than Ca
Degeneration of retinal ganglion cells (RGCs) is a prominent feature of various disorders including glaucoma, ischemia, and diabetic retinopathy. These pathological conditions may be associated with dysregulation of the glutamatergic system, leading to excitotoxic injury in the retina (1) . The mechanisms of excitotoxicity in RGCs remain controversial, however, due to the lack of suitable in vitro experimental systems for evaluation of RGC death. To circumvent this problem, we have established a novel system for evaluation of RGC death using posterior eyecups prepared from adult rats (2) . Using this preparation, we uncovered the dependence of acute excitotoxicity on extracellular Cl − rather than extracellular Ca 2+ (2) . However, the proportion of dead RGCs as assessed by propidium iodide staining was at most 15% of the total RGCs at 6 h after treatment with excitotoxins such as N-methyl-D-aspartate (NMDA) and kainate. Therefore, the present study was designed to evaluate the delayed phase of excitotoxicity that could not be detected by propidium iodide staining, because delayed apoptotic cell death may be relevant to RGC death during chronic disease states (3) . For this purpose, we focused on p53 expression.
The tumor suppressor protein p53 functions as a transcription factor that upregulates the expression of the pro-apoptotic gene bax and downregulates the expression of the anti-apoptotic gene bcl-2, thereby triggering apoptosis in many cell types (4) . Indeed, apoptosis induced by retinal ischemia is accompanied by increased expression of p53 mRNA (5), and mice heterozygous for the mutant p53 allele show resistance to RGC death induced by ischemia (6) . Moreover, p53 gene polymorphism may be related to the primary open angle glaucoma (7) .
Retrograde labeling of RGCs with fluoro-gold (FG; Fluorochrome, LLC, Denver, CO, USA) was performed on male 7-week-old Sprague-Dawley rats under anesthesia with pentobarbital as described (2) . Four days after FG injection, rats were killed by decapitation; and the eyeballs were obtained and transferred into petri dishes containing ice-cold artificial cerebrospinal fluid (aCSF) consisting of 124 mM NaCl, 5 mM KCl, 2 mM MgSO 4 , 2 mM CaCl 2 , 1.25 mM NaH 2 PO 4 , 22 mM NaHCO 3 , and 10 mM glucose. The posterior eyecups were dissected out and transferred into a sixwell plate, each well filled with 6 mL of aCSF maintained at 30°C. After incubation for 90 min, we treated the eyecups with kainate (Wako Chemicals, Osaka) by transferring them to a 12-well plate whose wells were filled with 3 mL of aCSF containing kainate at 30°C. After 30 min of treatment, the eyecups were again transferred into a six-well plate, each well filled with 6 mL of fresh aCSF, and incubated for a further 6 h. aCSF was saturated with 95% O 2 / 5% CO 2 throughout the experiments.
At termination of post-incubation, we fixed the eyecups in phosphate-buffered 4% formalin / 1% glutaraldehyde aqueous solution (pH 7.4) at 4°C overnight, and then, in phosphate-buffered 10% formalin solution (pH 7.4) at 4°C overnight. After fixation, we dehydrated the eyecups with ethanol and then immersed them in xylene. Eyecups were embedded in paraffin and cut into 5-μm sections through the optic nerve of each eyecup. The sections were then subjected to immunohistochemistry with anti-p53 antibody. For antigen retrieval, specimens were incubated in 10 mM citratebuffered solution (pH 6.0) at 80°C for 30 min. Specimens were then blocked with 1.5% goat serum in phosphate-buffered saline (PBS) at room temperature for 1 h. Following these processes, specimens were incubated with mouse anti-p53 antibody PAb1620 (20 μg/ ml, No. OP33; Calbiochem, Merck, Ltd., Tokyo) at 4°C overnight. After rinsing with PBS, specimens were incubated overnight with Alexa Fluor 568-labeled goat anti-mouse IgG (1:400; Molecular Probes, Eugene, OR, USA) at room temperature.
For each section, we randomly selected three fields of 300-μm length at approximately 1 mm from the optic disc and acquired fluorescence images. We counted FG-labeled, p53-positive (FG 
/p53
+ cells from that of p53-labeled cells. Retinal sections obtained from eyecups maintained in aCSF without kainate for 30 min and incubated for a further 6 h in aCSF contained very few p53-positive cells (Fig. 1A) . In contrast, p53-positive cells appeared when the eyecups were exposed to 1 mM kainate for 30 min and incubated for a further 6 h in aCSF (Fig. 1B) . Quantitative analysis revealed that 1 mM kainate caused a significant increase in p53-positive RGCs (FG + /p53 + cells) (Fig. 1C) . The number of p53-positive cells other than RGCs (FG − /p53 + cells) also significantly increased in response to kainate (Fig. 1D) . Induction of p53 by kainate was inhibited by 30 µM 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f] quinoxaline-7-sulfonamide (NBQX), a non-NMDA-receptor antagonist.
As we have previously found that Cl − influx is a critical event in acute excitotoxicity in the retina (2), we examined the effect of Cl − reduction on kainate-induced p53 expression by substituting Na methanesulfonate for NaCl during the entire course of incubation. Interestingly, reduction of extracellular Cl − did not prevent p53 induction by 1 mM kainate either in RGCs or in other cells in the GCL (Fig. 2: A and B) . We next examined the effect of Na + substitution since acute excitotoxicity in RGCs is partially dependent on extracellular Na + (2). Reduction of extracellular Na + , by substitution of choline Cl for NaCl, significantly increased p53 expression in RGCs by itself (Fig. 2C ). In addition, Na + substitution did not inhibit p53 induction by kainate in cells other than RGCs (Fig. 2D) . Thus, these results suggest that influx of Cl − and Na + is not important in kainateinduced p53 expression.
Accordingly, we set out to address the involvement of Ca 2+ influx in p53 expression. We could not evaluate the effect of extracellular Ca 2+ removal by the Ca 2+ chelator EGTA because retinal tissue detachment and damage were induced in EGTA-treated eyecups in the dehydration process. Therefore, we tested the effect of MDL 28170, a calpain inhibitor. Calpains are Ca
2+
-activated cysteine proteases that have been reported to mediate p53 activation evoked by DNA damage (8) . When MDL 28170 (100 μM) was applied 90 min before kainate treatment and was present during the entire course of incubation, the drug abolished the increase in p53-positive RGCs (Fig. 2E) . MDL 28170 also significantly inhibited kainate-induced increase in p53-positive cells other than RGCs (Fig. 2F) .
Here we revealed differences of the mechanisms between acute excitotoxicity and delayed excitotoxicity. Expression of p53, an early indicator of apoptotic cell death, was detected after 6 h of post-incubation following kainate treatment. DNA fragmentation may become prominent at later periods (9) that are beyond the time scale assessable in our eyecup preparation. Influx of Cl − has been frequently implicated in excitotoxic degeneration of neuronal cells of various regions (10) , and our previous study suggested that acute excitotoxic RGC death depends on Cl − influx through niflumic acidsensitive Cl − channels (2) . In sharp contrast, we found here that reduction of extracellular Cl − did not prevent kainate-induced p53 expression mediating delayed excitotoxicity in RGCs. On the other hand, MDL 28170 abolished p53 expression in RGCs induced by kainate, indicating that calpains play a crucial role in mediating delayed excitotoxicity. Because MDL 28170 also inhibits cathepsin B, the observed effect of the compound might have resulted from cathepsin B inhibition. However, to our knowledge, no literature has reported the involvement of cathepsin B in p53 expression. Ca 2+ influx following kainate application may occur via several Previous studies have pointed out potential involvement of calpains in retinal degeneration (11) and NMDA-induced excitotoxicity in adult rat retina (12) . To our knowledge, however, the relationship between calpain activation and p53 expression has not yet been investigated in the retina. Sedarous et al. (8) reported that calpains mediate p53 activation after DNA damage in mouse cortical neurons and proposed that calpainmediated activation of the NFκB pathway may regulate p53. Calpains are known to cleave IκB, a negative regulator of the NFκB pathway (13) , and NFκB can activate p53 through direct transcriptional mechanisms (14) . Alternatively, activation of cyclin-dependent kinase 5 through the cleavage of p35 to p25 by calpain may lead to p53 phosphorylation and activation (15) .
Overall, our previous study (2) and the present one uncovered an intriguing difference in ionic dependence of acute and delayed excitotoxicity in RGCs. In vitro experimental systems for evaluation of acute RGC death with propidium iodide staining in our previous study (2) and delayed RGC death with immunohistochemistry for p53 in the present study are useful for investigating the mechanisms of excitotoxicity in the retina and searching for new drugs protecting RGCs.
